Lower GI 2017

First page Table of contents Previous page 849 Next page Last page

rectal cancer OS improved from 81.5% to 83.9% (relative risk, 0.86)

Colon 71% / Rectal 29% Stage II 91% / Stage III 8%

survival

Made with